UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry

Autoimmunity reviews, 2016-12, Vol.15 (12), p.1120-1124

2016

Link zum Volltext

Verfügbarkeit prüfen

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

Journal of autoimmunity, 2018-08, Vol.92, p.1-11

2018

Link zum Volltext

Verfügbarkeit prüfen

16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

Lupus, 2020-10, Vol.29 (12), p.1594-1600

2020

Link zum Volltext

Verfügbarkeit prüfen

Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab

Autoimmunity reviews, 2013-09, Vol.12 (11), p.1085-1090

2013

Link zum Volltext

Verfügbarkeit prüfen

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

Autoimmunity reviews, 2014-07, Vol.13 (7), p.699-707

2014

Link zum Volltext

Verfügbarkeit prüfen

The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the “Catastrophic antiphospholipid syndrome registry”

Lupus, 2022-09, Vol.31 (10), p.1218-1225

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry

Lupus, 2022-02, Vol.31 (2), p.194-201

2022

Link zum Volltext

Verfügbarkeit prüfen

Catastrophic antiphospholipid syndrome: an update

Panminerva medica, 2017-09, Vol.59 (3), p.254

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review

Frontiers in immunology, 2022-08, Vol.13, p.967178-967178

2022

Link zum Volltext

Verfügbarkeit prüfen

Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature

Lupus, 2021-05, Vol.30 (6), p.1005-1009

2021

Link zum Volltext

Verfügbarkeit prüfen

Pediatric catastrophic antiphospholipid syndrome: Descriptive analysis of 45 patients from the “CAPS Registry”

Autoimmunity reviews, 2014-02, Vol.13 (2), p.157-162

2014

Link zum Volltext

Verfügbarkeit prüfen

Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome

Therapeutic Advances in Musculoskeletal Disease, 2015-02, Vol.7 (1), p.26-30

2015

Link zum Volltext

Verfügbarkeit prüfen

“Non-criteria” antiphospholipid syndrome: A nomenclature proposal

Autoimmunity reviews, 2020-12, Vol.19 (12), p.102689, Article 102689

2020

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Noninvasive Vagus Nerve Stimulation for Systemic Lupus Erythematosus: Protocol for a Multicenter Randomized Controlled Trial

JMIR research protocols, 2023-10, Vol.12, p.e48387-e48387

2023

Link zum Volltext

Verfügbarkeit prüfen

Relapsing Catastrophic Antiphospholipid Syndrome Potential Role of Microangiopathic Hemolytic Anemia in Disease Relapses

Seminars in arthritis and rheumatism, 2013-02, Vol.42 (4), p.417-423

2013

Link zum Volltext

Verfügbarkeit prüfen

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

Autoimmunity reviews, 2022-04, Vol.21 (4), p.103055, Article 103055

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the “CAPS registry”

Seminars in arthritis and rheumatism, 2024-06, Vol.66, p.152439-152439, Article 152439

2024

Link zum Volltext

Verfügbarkeit prüfen

Catastrophic APS in the Context of Other Thrombotic Microangiopathies

Current rheumatology reports, 2015, Vol.17 (1), p.482-482, Article 3

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis

Seminars in arthritis and rheumatism, 2014-06, Vol.43 (6), p.772-777

2014

Link zum Volltext

Verfügbarkeit prüfen

Peripheral nervous system involvement in systemic lupus erythematosus: Prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre

Autoimmunity reviews, 2017-07, Vol.16 (7), p.750-755

2017

Link zum Volltext

Verfügbarkeit prüfen

Plasma exchange in catastrophic antiphospholipid syndrome

La Presse médicale (1983), 2019-11, Vol.48 (11), p.347-353

2019

Link zum Volltext

Verfügbarkeit prüfen

Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines

Expert review of hematology, 2021-05, Vol.14 (5), p.457-466

2021

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever

Autoimmunity reviews, 2015-07, Vol.14 (7), p.586-593

2015

Link zum Volltext

Verfügbarkeit prüfen

The problems and pitfalls in systemic lupus erythematosus drug discovery

Expert opinion on drug discovery, 2016-06, Vol.11 (6), p.525-527

2016

Link zum Volltext

Verfügbarkeit prüfen

Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?

Arthritis care & research (2010), 2024-01, Vol.76 (1), p.88-97

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(54)
Humans
(43)
Antiphospholipid Syndrome
(29)
Rheumatology
(28)
Immunology
(22)
Female
(20)
Catastrophic Antiphospholipid Syndrome
(19)
Antiphospholipid Antibodies
(18)
Male
(17)
Autoimmune Diseases
(16)
Adult
(14)
Middle Aged
(13)
Systemic Lupus Erythematosus
(10)
Thrombosis
(10)
Antiphospholipid Syndrome - Complications
(9)
Registries
(9)
Systemic Sclerosis
(9)
Antibodies, Antiphospholipid
(8)
Antiphospholipid Syndrome - Diagnosis
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the “Catastrophic antiphospholipid syndrome registry”

Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry

Catastrophic antiphospholipid syndrome: an update

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review

Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature

Pediatric catastrophic antiphospholipid syndrome: Descriptive analysis of 45 patients from the “CAPS Registry”

Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome

“Non-criteria” antiphospholipid syndrome: A nomenclature proposal

Optimizing Noninvasive Vagus Nerve Stimulation for Systemic Lupus Erythematosus: Protocol for a Multicenter Randomized Controlled Trial

Relapsing Catastrophic Antiphospholipid Syndrome Potential Role of Microangiopathic Hemolytic Anemia in Disease Relapses

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the “CAPS registry”

Catastrophic APS in the Context of Other Thrombotic Microangiopathies

Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis

Peripheral nervous system involvement in systemic lupus erythematosus: Prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre

Plasma exchange in catastrophic antiphospholipid syndrome

Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines

Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever

The problems and pitfalls in systemic lupus erythematosus drug discovery

Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?

Suchergebnisse filtern